FDA yesterday granted accelerated approval for mirvetuximab soravtansine-gynx (Elahere, Immunogen) for the treatment of adult patients with folate receptor alpha (FRα)-positive, platinum-resistant epithelial ovarian, fallopian
Healthcare professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse
Over the weekend, FDA Commissioner Robert M. Califf tested positive for COVID-19 while traveling on official agency business. FDA said he is up-to-date on vaccines
The shortage of the immediate-release formulation of amphetamine mixed salts (Adderall or Adderall IR) announced earlier this month by FDA has the potential to lead
Despite the threat of a “tridemic” with RSV, influenza, and SARS-CoV-2, fewer than 10% of eligible Americans have received a bivalent COVID-19 booster dose, and
Another COVID-19 vaccine booster formulation could be needed by next Sept. or Oct., FDA vaccines chief Peter Marks told Stat. SARS-CoV-2 is mutating at a
Clinicians should be aware of a “recent rapid increase in certain SARS-CoV-2 Omicron subvariants circulating in the United States,” the NIH COVID-19 Treatment Guidelines Panel
The FDA yesterday issued an emergency use authorization (EUA) for the first over-the-counter molecular test authorized for use with saliva specimens to Aptitude Medical Inc. for their
FDA announced yesterday it has awarded 19 new grants and 2 new contracts totaling more than $38 million in funding over the next 4 years
Children as young as 5 years of age can now receive booster doses of either of the 2 available bivalent mRNA vaccines for COVID-19, FDA